MedPath

First Affiliated Hospital of Wenzhou Medical University

People's Republic of China
Ownership
Private
Established
1956-01-01
Employees
-
Market Cap
-
Website
http://www.dyyy.xjtu.edu.cn/

Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies

Conditions
Hepatocellular Carcinoma
Sarcopenia
First Posted Date
2022-07-07
Last Posted Date
2023-09-13
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
300
Registration Number
NCT05448222
Locations
🇨🇳

Gang Chen, Wenzhou, Zhejiang, China

Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments

Conditions
Adverse Event
Liver Cancer
Microbiota
Efficacy
Prognosis
Interventions
Diagnostic Test: questionnaire survey
First Posted Date
2022-07-05
Last Posted Date
2023-09-13
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
200
Registration Number
NCT05443217
Locations
🇨🇳

Gang Chen, Wenzhou, Zhejiang, China

Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment

Conditions
Liver Cancer
Sarcopenia
Interventions
Diagnostic Test: gait speed; ct scan; grip strength and chair stand test
First Posted Date
2022-07-05
Last Posted Date
2023-09-13
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
200
Registration Number
NCT05443230
Locations
🇨🇳

Gang Chen, Wenzhou, Zhejiang, China

The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.

Phase 2
Recruiting
Conditions
Diffuse Large B Cell Lymphoma
Interventions
Drug: Zanubrutinib+Rituximab+Lenalidomide
Drug: RCHOP/RCDOP
First Posted Date
2022-06-23
Last Posted Date
2022-06-23
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
150
Registration Number
NCT05428670
Locations
🇨🇳

First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Relationship Between Liver Cancer and Sarcopenia

Conditions
Sarcopenia
Liver Cancer
First Posted Date
2022-04-21
Last Posted Date
2022-06-15
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
1200
Registration Number
NCT05339919
Locations
🇨🇳

Gang Chen, Wenzhou, Zhejiang, China

mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer

Phase 2
Recruiting
Conditions
Colorectal Cancer
Interventions
Drug: mFOLFOXIRI
Drug: mFOLFOX6 OR CapeOx
First Posted Date
2022-01-20
Last Posted Date
2022-01-20
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
100
Registration Number
NCT05200299
Locations
🇨🇳

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis

Completed
Conditions
Digestive Tract Diseases
Liver Diseases
Colorectal Disease
Gastric Diseases
Small Bowel Disease
Interventions
Other: Tongue images,coating on the tongue and clinical data
First Posted Date
2022-01-10
Last Posted Date
2022-06-16
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
10690
Registration Number
NCT05182983
Locations
🇨🇳

Gang Chen, Wenzhou, Zhejiang, China

Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics

Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2021-10-06
Last Posted Date
2021-10-06
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
13000
Registration Number
NCT05069194
Locations
🇨🇳

The first affiliated hospital of wenzhou medical university, Wenzhou, Zhejiang, China

Effect of a WeChat Platform-based Management Intervention on Blood Pressure Control

Not Applicable
Conditions
Hypertension
Interventions
Other: WeChat platform group
First Posted Date
2020-12-23
Last Posted Date
2021-02-09
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
436
Registration Number
NCT04682015

Fecal Microbiota Transplantation in Cirrhosis

Not Applicable
Conditions
Cirrhosis, Liver
Interventions
Other: Healthy fecal bacteria liquid
First Posted Date
2020-10-19
Last Posted Date
2020-10-19
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
100
Registration Number
NCT04591522
© Copyright 2025. All Rights Reserved by MedPath